Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
From the National Centre for Research and Development in Poland:
Published in major journals, first or last author from Oslo University Hospital.
Schuppan D, Mäki M, Lundin KEA(2021) A Trial of a Transglutaminase 2 Inhibitor in Celiac Disease. Reply N Engl J Med, 385(16), e57 DOI 10.1056/NEJMc2112688, PubMed 34644485
Dueland S, Yaqub S, Line PD(2021) No Strong Evidence on Liver Transplant for Colorectal Cancer Liver Metastasis Over Portal Vein Embolization Associated With Liver Resection-Reply JAMA Surg(in press) DOI 10.1001/jamasurg.2021.5127, PubMed 34643668
Martens-Uzunova ES, Blijdorp CJ, Burger D, Erdbrügger U, Llorente A(2021) Urinary Extracellular Vesicles in Urology: Current Successes and Challenges Ahead Eur Urol(in press) DOI 10.1016/j.eururo.2021.09.025, PubMed 34625312